Please login to the form below

Not currently logged in

AZ and MSD win FDA priority review for Lynparza in breast cancer

AstraZeneca AZCould become the first PARP inhibitor to be approved in the US for the disease

CHMP recommends Teva's generic version of Astellas' Advagraf

TevaCommittee backs the drug for transplant rejection prophylaxis

NICE backs Pfizer’s Xeljanz for RA

Pfizer Xeljanz tofacitinib tabletsBut UK’s cost-effectiveness watchdog removes two drugs from CDF

SMC backtracks on Janssen’s multiple myeloma treatment Darzalex

Janssen logoWill now recommend the first-in-class treatment after securing a discount

AZ starts pursuit of lung cancer indication for Imfinzi

AstraZeneca AZAnd its EGFR inhibitor Tagrisso picks up US breakthrough status

EMA sets aside £32m for temporary staff to help with Brexit move

EMA relocationAs agency warns current tender system needs to be updated

AAA’s orphan drug Lutathera wins EU green light

AAAThe first-in-class drug treats adults with GEP-NET

FDA grants orphan drug status to UniQure’s Huntington’s Disease treatment

Becomes first investigational gene therapy to receive ODD for the disease

KeysMoving times

Continuity and stability are vital when it comes to the EMA's relocation when it leaves London

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...